Comparison of the QuikRead go
colorectal cancer
faecal immunochemical testing
point of care testing
Journal
Clinical chemistry and laboratory medicine
ISSN: 1437-4331
Titre abrégé: Clin Chem Lab Med
Pays: Germany
ID NLM: 9806306
Informations de publication
Date de publication:
26 01 2022
26 01 2022
Historique:
received:
05
06
2021
accepted:
08
10
2021
pubmed:
23
10
2021
medline:
16
3
2022
entrez:
22
10
2021
Statut:
epublish
Résumé
Faecal immunochemical testing for haemoglobin (FIT) is used to triage patients for colonic investigations. Point-of-care (POC) FIT devices on the market have limited data for their diagnostic accuracy for colorectal cancer (CRC). Here, a POC FIT device is compared with a laboratory-based FIT system using patient collected samples from the urgent referral pathway for suspected CRC. A prospective, observational cohort study. Patients collected two samples from the same stool. These were measured by POC QuikRead go A total of 629 included patients provided paired samples for FIT to compare the QuikRead go Both systems were accurate in their ability to detect CRC. Whilst good agreement around the negative threshold was identified, more patients would be triaged to further colonic investigation if using the QuikRead go
Identifiants
pubmed: 34679264
pii: cclm-2021-0655
doi: 10.1515/cclm-2021-0655
doi:
Substances chimiques
Hemoglobins
0
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
101-108Informations de copyright
© 2021 William Maclean et al., published by De Gruyter, Berlin/Boston.
Références
Nicholson, B, Thompson, M, Price, CP, Heneghan, C, Pluddemann, A. Point-of-Care faecal occult blood testing. Horiz Scan Rep 0035 [Internet] 2014:85–94. Available from: https://www.community.healthcare.mic.nihr.ac.uk/reports-and-resources/horizon-scanning-reports/point-of-care-faecal-occult-blood-testing.
Nicholson, BD, Price, CP, Heneghan, C, Plüddemann, A, Thompson, M. Home-use faecal immunochemical testing: primary care diagnostic technology update. Br J Gen Pract 2015;65:156–8. https://doi.org/10.3399/bjgp15x684229.
Gies, A, Cuk, K, Schrotz-King, P, Brenner, H. Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening. Clin Transl Gastroenterol 2018;9:168. https://doi.org/10.1038/s41424-018-0035-2.
Gies, A, Cuk, K, Schrotz-King, P, Brenner, H. Combination of different fecal immunochemical tests in colorectal cancer screening: any gain in diagnostic performance? Cancers 2019;11:16–8. https://doi.org/10.3390/cancers11010120.
Tsapournas, G, Hellström, PM, Cao, Y, Olsson, LI. Diagnostic accuracy of a quantitative faecal immunochemical test vs. symptoms suspected for colorectal cancer in patients referred for colonoscopy. Scand J Gastroenterol 2020;55:184–92. https://doi.org/10.1080/00365521.2019.1708965.
Huddy, JR, Ni, MZ, Markar, SR, Hanna, GB. Point-of-care testing in the diagnosis of gastrointestinal cancers: current technology and future directions. World J Gastroenterol 2015;21:4111–20. https://doi.org/10.3748/wjg.v21.i14.4111.
National Institute for Health and Care Excellence. Quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care Diagnostics guidance [Internet]. Diagnostics Guidance DG30; 2017. Available from: https://www.nice.org.uk/guidance/dg30/resources/quantitative-faecal-immunochemical-tests-to-guide-referral-for-colorectal-cancer-in-primary-care-pdf-1053744003781 [Accessed 15 Aug 2021].
O’Driscoll, S, Carroll, M, Maclean, W, Piggott, C, Jourdan, I, Benton, SC. Assessment of the analytical performance of point-of-care faecal immunochemical tests for haemoglobin. Ann Clin Biochem 2021;58:181–9.
Huddy, JR, Ni, M, Misra, S, Mavroveli, S, Barlow, J, Hanna, GB. Development of the point-of-care key evidence tool (POCKET): a checklist for multi-dimensional evidence generation in point-of-care tests. Clin Chem Lab Med 2019;57:845–55. https://doi.org/10.1515/cclm-2018-1089.
Piggott, C, Carroll, MRR, John, C, O’Driscoll, S, Benton, SC. Analytical evaluation of four faecal immunochemistry tests for haemoglobin. Clin Chem Lab Med 2021;59:173–8. https://doi.org/10.1515/cclm-2020-0251.
Westwood, M, Ramos, IC, Lang, S, Luyendijk, M, Zaim, R, Stirk, L, et al.. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: A systematic review and cost-effectiveness analysis. Health Technol Assess 2017;21:1–234. https://doi.org/10.3310/hta21330.
D’Souza, N, Hicks, G, Benton, SC, Abulafi, M. The diagnostic accuracy of the faecal immunochemical test for colorectal cancer in risk-stratified symptomatic patients. Ann R Coll Surg Engl 2019;102:174–9.
National Institute for Health and Care Excellence. Suspected cancer: recognition and referral NICE guideline [Internet]. Available from: https://www.nice.org.uk/guidance/ng12https://www.nice.org.uk/guidance/ng12/resources/suspected-cancer-recognition-and-referral-pdf-1837268071621 [Accessed 15 Aug 2021].
Martín-López, JE, Beltrán-Calvo, C, Rodríguez-López, R, Molina-López, T. Comparison of the accuracy of CT colonography and colonoscopy in the diagnosis of colorectal cancer. Colorectal Dis 2014;16:82–90. https://doi.org/10.1111/codi.12506.
Rutter, MD, East, J, Rees, CJ, Cripps, N, Docherty, J, Dolwani, S, et al.. British society of gastroenterology/association of coloproctology of great Britain and Ireland/public health England post-polypectomy and post-colorectal cancer resection surveillance guidelines. Gut 2020;69:201–23. https://doi.org/10.1136/gutjnl-2019-319858.
Fraser, CG, Allison, JE, Young, GP, Halloran, SP, Seaman, H. A standard for faecal immunochemical TesTs for haemoglobin evaluation reporting (FITTER). Ann Clin Biochem 2014;51:301–2. https://doi.org/10.1177/0004563213514392.
Auge, JM, Rodriguez, C, Espanyol, O, Rivero, L, Sandalinas, S, Grau, J, et al.. An evaluation of the SENTiFIT 270 analyser for quantitation of faecal haemoglobin in the investigation of patients with suspected colorectal cancer. Clin Chem Lab Med 2018;56:625–33. https://doi.org/10.1515/cclm-2017-0605.
Gisev, N, Hons, BP, Bell, JS, Chen, TF. Interrater agreement and interrater reliability : key concepts , approaches, and applications. Res Soc Adm Pharm 2013;9:330–8. https://doi.org/10.1016/j.sapharm.2012.04.004.
Garrett, PE. User protocol for evaluation of qualitative test performance; Approved Guideline – Second Edition. CLSI/NCCLS Doc EP12-A2, Approv Guidel, 2nd Ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008:28 p.
DeLong, ER, DeLong, DM, Clarke-Pearson, DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837–45. https://doi.org/10.2307/2531595.
Chapman, CJ, Banerjea, A, Humes, DJ, Allen, J, Oliver, S, Ford, A, et al.. Choice of faecal immunochemical test matters: comparison of OC-Sensor and HM-JACKarc, in the assessment of patients at high risk of colorectal cancer. Clin Chem Lab Med 2021;59:721–8. https://doi.org/10.1515/cclm-2020-1170.
Arasaradnam, RP, Bhala, N, Evans, C, Greenaway, J, Logan, R, Penman, I, et al.. Faecal immunochemical testing in the COVID-19 era: balancing risk and costs. Lancet Gastroenterol Hepatol 2020;5:717–9. https://doi.org/10.1016/s2468-1253(20)30185-0.
Tolley, T, Whewell, H, Davies, DR, Codd, RJ, Swarnkar, KJ, Williams, GL. Colorectal cancer referrals during the COVID-19 pandemic: the utility of CT and faecal immunochemical testing. Br J Surg 2021;108:E119–20. https://doi.org/10.1093/bjs/znaa140.
Maclean, W, Limb, C, Mackenzie, P, Whyte, MB, Benton, SC, Rockall, T, et al.. Adoption of faecal immunochemical testing for 2-week-wait colorectal patients during the COVID-19 pandemic: an observational cohort study reporting a new service at a regional centre. Colorectal Dis 2020;23:1622–9. https://doi.org/10.1111/codi.15408.
O’Driscoll, S, Piggott, C, Bruce, H, Benton, SC. An evaluation of ten external quality assurance scheme (EQAS) materials for the faecal immunochemical test (FIT) for haemoglobin. Clin Chem Lab Med 2021;59:307–13. https://doi.org/10.1515/cclm-2020-0210.
Benton, SC, Symonds, E, Djedovic, N, Jones, S, Deprez, L, Kocna, P, et al.. Faecal immunochemical tests for haemoglobin: analytical challenges and potential solutions. Clin Chim Acta 2021;517:60–5. https://doi.org/10.1016/j.cca.2021.01.024.
Chiang, TH, Chuang, SL, Chen, SLS, Chiu, HM, Yen, AMF, Chiu, SYH, et al.. Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program. Gastroenterology 2014;147:1317–26. https://doi.org/10.1053/j.gastro.2014.08.043.
D’Souza, N, Delisle, TG, Chen, M, Benton, S, Abulafi, M. Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study. Gut 2021;70:1130–8. https://doi.org/10.1136/gutjnl-2020-321956.
Khan, AA, Klimovskij, M, Harshen, R. Accuracy of faecal immunochemical testing in patients with symptomatic colorectal cancer. BJS Open 2020;4:1180–8. https://doi.org/10.1002/bjs5.50346.
Grainger, J, Skaife, P. PWE-338 Digital rectal examination: a discriminatory test in the diagnosis of colo rectal cancer: abstract PWE-338 Table 1. Gut 2015;64:A358. https://doi.org/10.1136/gutjnl-2015-309861.784.